Voglinorm-0.2/Voglinorm-0.3

Voglinorm-0.2/Voglinorm-0.3 Special Precautions

voglibose

Manufacturer:

Micro Labs

Distributor:

Zizawa Healthcare
Full Prescribing Info
Special Precautions
Patients with history of laparotomy or ileus; patients with chronic intestinal disease accompanied by disturbance in digestion and absorption; patients with aggravating symptoms due to increased generation of intestinal gas (eg, Roemheld syndrome, severe hernia and stenosis, and ulcer of the large intestine) and patients with serious hepatic or renal disorders.
All patients should continue their dietary restriction with a regular distribution of carbohydrate intake during the day.
Overweight patients should continue their energy restricted diet.
Patients should be instructed and explained to recognize hypoglycemic symptoms and its management.
When patients with diabetes are exposed to unusual stress eg, fever, trauma, infection, or surgery, a temporary loss of control of blood glucose may occur. At such times insulin therapy may be necessary for some time.
Use in pregnancy: To date, no relevant epidemiological data are available. Animal studies do not indicate harmful effects with respect to pregnancy, embryonal or fetal development, parturition or postnatal development, therefore, Voglinorm-0.2/Voglinorm-0.3 should be given to pregnant women or women suspected of being pregnant only when the potential benefits outweigh the possible hazards.
Use in lactation: Voglibose is excreted into milk in lactating rats. Similar data is not available in humans and a decision should be made whether to discontinue nursing or to discontinue voglibose in taking into account the benefit of using the compound in the mother. Animal studies (rats) have revealed a suppressive action of voglibose on body weight increase in newborns presumably due to suppression of milk production in mother animals resulting from suppression of carbohydrate absorption. Therefore, it is desirable not to give voglibose to women during lactation. When the administration is unavoidable, nursing should be avoided.
Use in children: The safety and effectiveness of voglibose in children has not been established.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in